Who owns Progenics Pharmaceuticals?

Key details on Progenics Pharmaceuticals (Ticker: PGNX)

Who owns Progenics Pharmaceuticals?

Is PGNX a good stock to own? Find out who bought Progenics Pharmaceuticals, who sold Progenics Pharmaceuticals (PGNX) stock, and who holds a large position in Progenics Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
Federated Investors 13.51M $80.78M March 31, 2015
Broadfin Capital 9.15M $69.18M Dec. 31, 2014
FMR 5.45M $32.62M March 31, 2015
Baker Bros. Advisors 4.35M $26.02M March 31, 2015
STATE STREET CORPORATION 4.13M $24.68M March 31, 2015
BlackRock Fund Advisors 2.79M $16.70M March 31, 2015
Tudor Investment Corporation 2.34M $14.01M March 31, 2015
Vanguard 2.22M $13.28M March 31, 2015
BlackRock Institutional Trust Company, N.A. 2.08M $12.44M March 31, 2015
Royce & Associates 1.71M $10.21M March 31, 2015
Highland Capital Management 1.59M $8.25M Sept. 30, 2014
Wellington Management Company 1.48M $8.84M March 31, 2015
Tiger Management 1.29M $9.74M Dec. 31, 2014
MORGAN STANLEY 1.14M $5.70M Sept. 30, 2013
Oxford Asset Management 1.10M $8.36M Dec. 31, 2014
Phocas Financial 1.05M $7.92M Dec. 31, 2014
Deerfield Management Company 1.04M $5.60M March 31, 2013

Who sold Progenics Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
Perceptive Advisors Dec. 31, 2010 1.17M $6.38M